Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05451563 · ClinicalTrials.gov registry record · NA
Double-S: a Wearable Device for Erectile Dysfunction
A NA study of Erectile Dysfunction, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05451563: Recruiting NA study of Erectile Dysfunction, sponsored by Stanford University.
NCT05451563 is a NA study of Erectile Dysfunction that is actively recruiting participants, run by Stanford University. The registered enrollment target is 10 participants, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05451563, a NA study of Erectile Dysfunction, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to use a minimally invasive erectile device for patients suffering from erectile dysfunction.
Primary Outcome
score 0 to 30 with higher score meaning better erectile function
Conditions Studied
Interventions
- DEVICE Double-S
Study Locations (1)
California
- Stanford Healthcare, Stanford Hospital - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-03-21 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT05451563 shows while recruiting
NCT05451563 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 231-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Double-S is the first listed.
NCT05451563 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05451563 about?
NCT05451563 is a clinical study titled "Double-S: a Wearable Device for Erectile Dysfunction". The purpose of this study is to use a minimally invasive erectile device for patients suffering from erectile dysfunction.
What is the current status of trial NCT05451563?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-03-21. Estimated completion is 2026-06.
What conditions does trial NCT05451563 study?
This clinical trial studies the following conditions: Erectile Dysfunction.
What interventions are being tested in trial NCT05451563?
The interventions under investigation include: Double-S (DEVICE).
Who is sponsoring clinical trial NCT05451563?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05451563 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05451563's enrollment target sits among peer trials
10 30th of 33 higher than 4 of 33 other Erectile Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Erectile Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
RECRUITING · NA
-
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
RECRUITING · NA
-
The Impact of Dietary Pattern on Erectile Function
RECRUITING · NA
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
-
The Impact of a Plant-based Meat Meal Versus an Animal Meat Meal on Erectile Function in Healthy Men.
RECRUITING · NA
-
Penile Lengthening Pre-Penile Prosthesis Implantation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI